Sasan Roayaie

ASSOCIATE PROFESSOR Surgery
ASSOCIATE PROFESSOR Medicine, Liver Diseases

Print Profile

Email

sasan.roayaie@mssm.edu

Specialty

Surgical Oncology

Certifications

American Board of Surgery

Clinical Focus

Education

MD, New Jersey Medical School
Residency, Surgery
Mount Sinai Hospital
Residency, Surgery
Mount Sinai Hospital
Fellowship, Transplant Surgery
Mount Sinai Hospital
Fellowship, Liver Transplant
Mount Sinai Hospital

Biography

Dr. Roayaie's areas of interest are adult liver transplantation including cadaver and living donor; and hepatobiliary surgery involving resection of tumors of the liver, bile ducts, and pancreas.

Dr. Roayaie earned his M.D. from the New Jersey Medical School. He was a member of the house staff at The Mount Sinai Hospital Department of Surgery before completing his Multiorgan Transplant fellowship here at RMTI. Among his many honors are the NIH K-30 Clinical Investigator Training Award in 2001; the Alpha Omega Alpha National Honor Society, member since 1993; and the Phi Beta Kappa National Honor Society, member since 1989. He also participated as a volunteer surgeon in Doctors Without Borders on an African Medical Mission to Transkei, South Africa. Dr. Roayaie is certified by the American Board of Surgery.

Awards

2001 -
NIH K-30 Clinical Investigator Training AwardNew award
2000 -
David A Dreiling Award for Best Academic Achievement among Chief Residents
1994 -
Drs. Milton & Rose Prystowsky Award for Overall Excellence in Patient Care
1993 -
Alpha Omega Alpha National Honor Society

Research

Hepatobiliary surgery
Benign and Malignant Tumors
Hepatocellular Carcinoma

Dr. Roayaie's research activities are focused on the results of transplantation and liver resection for hepatocellular carcinoma; the prevention of recurrence of hepatocellular carcinoma after resection and transplant; and the results of transplant and re-transplant for hepatitis C.

Publications

Roayaie S, Guarrera M, Ye M, Thung S, Emre S, Fishbein T, Guy S, Sheiner P, Miller C, Schwartz M. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcome. J Am Coll Surg 1998; 187: 365-372.

Roayaie S, Wang L, Basile J, Boros P, Miller C. The influence of acute hepatic failure in the host on survival and function of cold preserved liver allografts. Surgical Forum 1998 XLIX;: 388-390.

Roayaie S, Sheiner P, Emre S, Guy S, Schwartz M, Boros P, Miller C. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients. Mediators of Inflammation 2000; 9: 125-130.

Roayaie S, Jossart G, Gitlitz D, Lamparello P, Hollier L, Gagner M. Laparoscopic release of celiac artery compression syndrome facilitated by laparoscopic ultrasonography to confirm restoration of flow. J Vasc Surg 2000; 32: 814-817.

Roayaie S, Emre S, Fishbein T, Sheiner P, Miller C, Schwartz M. Comparison of surgical outcomes for hepatocellular carcinoma in patients with and hepatitis B vs. hepatitis C. Ann Surg Onc 2000; 7: 764-770.

Roayaie S, Frischer S, Emre S, Fishbein T, Sheiner P, Sung M, Miller C, Schwartz M. Long term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5cm. Ann Surg 2002; 235: 533-539.

Munoz L, Roayaie S, Maman D, Fishbein T, Sheiner P, Emre S, Miller C, Schwartz M. Hilar cholangiocarcinoma involving the portal vein bifurcation: Long term results after resection . J Hepatobiliary Pancreat Surg 2002; 9(2): 237-241.

Gondolesi G, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein T, Emre S, Miller C, Schwartz ME. Adult Living Donor Liver Transplantation for Patients with Hepatcocellular Carcinoma. Annals of Surgery 2004 Feb; 239(2): 142-149.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Roayaie during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Scientific Advisory Board:

Bayer

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central